关注
Kyle John Wilby
Kyle John Wilby
Associate Professor of Program Evaluation, Dalhousie University
在 dal.ca 的电子邮件经过验证 - 首页
标题
引用次数
年份
A comparison of warfarin utilisation in North America and Ireland
H Haji, K Wilby, M Mamdani
Journal of Health Specialties 2 (3), 105-105, 2014
2014
A course-based cross-cultural interaction among pharmacy students in Qatar and Canada
KJ Wilby, J Taylor, SI Khalifa, D Jorgenson
American journal of pharmaceutical education 79 (2), 26, 2015
182015
A critical evidence-based summary of the use of beta-blockers in stable coronary artery disease
AL Cartwright, KJ Wilby
Avicenna 2014 (1), 4, 2015
2015
A critical review of the current evidence for measuring drug concentrations of first-line agents used to treat tuberculosis in children
KJ Wilby, S Shabana, MHH Ensom, F Marra
Clinical pharmacokinetics 55, 17-31, 2016
22016
A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline
TKL Kiang, KJ Wilby, MHH Ensom
Clinical pharmacokinetics 54, 915-931, 2015
362015
A Middle Eastern journey of integrating Interprofessional Education into the healthcare curriculum: a SWOC analysis
A El-Awaisi, KJ Wilby, K Wilbur, MS El Hajj, A Awaisu, B Paravattil
BMC medical education 17, 1-10, 2017
592017
A narrative review of continuing professional development needs for pharmacists with respect to pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
KJ Wilby, AJ Smith
Pharmacy 8 (2), 84, 2020
162020
A psychometric analysis of a newly developed summative, multiple choice question assessment adapted from Canada to a Middle Eastern context
SA Pawluk, K Shah, R Minhas, D Rainkie, KJ Wilby
Currents in Pharmacy Teaching and Learning 10 (8), 1026-1032, 2018
92018
A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies
KJ Wilby, ZG Nasr, S Elazzazy, TTY Lau, A Hamad
Drugs in R&D 17, 73-78, 2017
32017
A review of clinical pharmacokinetic and pharmacodynamic relationships and clinical implications for drugs used to treat multi-drug resistant tuberculosis
KJ Wilby, FN Hussain
European Journal of Drug Metabolism and Pharmacokinetics 45 (3), 305-313, 2020
62020
A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients
KJ Wilby, ED Greanya, JAE Ford, EM Yoshida, N Partovi
Annals of hepatology 11 (2), 179-185, 2012
932012
A review of pharmacogenetics of antimalarials and associated clinical implications
H Elewa, KJ Wilby
European journal of drug metabolism and pharmacokinetics 42, 745-756, 2017
392017
A review of pharmacokinetic drug–drug interactions with the anthelmintic medications albendazole and mebendazole
SA Pawluk, CA Roels, KJ Wilby, MHH Ensom
Clinical pharmacokinetics 54, 371-383, 2015
602015
A review of pharmacy‐led interventions: identification of facilitators and barriers for the design of a new model of care for asthma
N Rajballi‐Naidoo, KJ Wilby, A Young, A Smith
Journal of Pharmacy Practice and Research 53 (5), 227-240, 2023
2023
A review of the clinical pharmacokinetics and pharmacodynamics of isavuconazole
KJ Wilby
European Journal of Drug Metabolism and Pharmacokinetics 43, 281-290, 2018
142018
A review of the effect of immunization programs on antimicrobial utilization
KJ Wilby, D Werry
Vaccine 30 (46), 6509-6514, 2012
452012
A review of the pharmacokinetic implications of schistosomiasis
KJ Wilby, SE Gilchrist, MHH Ensom
Clinical pharmacokinetics 52, 647-656, 2013
162013
A scoping review of antimicrobial stewardship teaching in pharmacy education curricula
ZG Nasr, DM Abbara, KJ Wilby
American Journal of Pharmaceutical Education 85 (6), 8415, 2021
92021
A scoping review of interprofessional education training aimed to improve 2SLGBTQ+ Health
M McLean, D Bogle, C Diggins, M MacInnis, A MacDonald, KJ Wilby
American Journal of Pharmaceutical Education, 100683, 2024
12024
A scoping review of the clinical pharmacokinetics of bedaquiline
KJ Wilby
Clinical Pharmacokinetics 61 (4), 481-488, 2022
52022
系统目前无法执行此操作,请稍后再试。
文章 1–20